Article
The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M.
Oncotarget - 26 Jul 2016
Tseng Jeng-Sen, Su Kang-Yi, Yang Tsung-Ying, Chen Kun-Chieh, Hsu Kuo-Hsuan, Chen Hsuan-Yu, Tsai Chi-Ren, Yu Sung-Liang, Chang Gee-Chen
Abstract excerpt
Different growth kinetics occurring between the sensitive and T790M-containing cells may result in the repopulation of tumor cells over time. Little information has yet been uncovered on whether rebiopsy timing influences the T790M detection rate. We enrolled a total of 98 epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma patients, who had a history of acquired resistance to EGFR-tyrosine kinase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
